Monte Rosa Therapeutics GLUE Climbs 165 as Bullish Price Action Tests Key Resistance Mixed Q4 Results IndiGo Reports Loss Asian Paints Profit Rises Amid Sector Divergence RY Q1 2026 Earnings EPS Beat Expectations Stock Edges Lower Breakaway Gaps A Traders Guide to Buying Strength and Managing Risk